There is a new rule of evidence in New Jersey that seeks to clarify the plethora of privileges governing confidential communications between mental health service providers and patients suffering from mental or emotional health conditions.
In our previous post we outlined the key issues regarding mHealth devices and services from a privacy law perspective.
On October 5, the Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services launched a new platform to enable developers of mobile health technology, as well as others “interested in the intersection of health information technology and HIPAA privacy protection.”
On October 6, 2015, the Centers for Medicare and Medicaid Services (CMS) published a final rule for Stage 3 of the Electronic Health Record (EHR) Incentive Program.
On October 6, 2015, the HHS Office of Inspector General (OIG) issued guidance addressing its policy on the offer of electronic health record (EHR) technology that is purposefully limited in interoperability among providers.
Clinical Laboratories: Proposed Rule Implements Requirements for Reporting and Payment Based On Private Payer Rates
As required by a 2014 statute, CMS has issued proposed regulations (Proposed Rule) implementing new requirements for laboratory reporting of, and eventually basing Medicare payment on, rates for clinical laboratory services paid by private payers.
We have now had more than 30 days to digest HRSA’s proposed 340B Drug Pricing Program Omnibus Guidance (“Proposed Guidance”), intended to clarify expectations and provide guidance on key issues in the 340B Program.
On October 5, 2015, the HHS Office of Civil Rights (OCR) unveiled a new resource to provide mobile health (mHealth) developers guidance on complying with Health Information Portability and Accountability Act (HIPAA) requirements applicable to those organizations.
As companies continue to implement mobile health apps, aggregate clinical trial results, and isolate disease through computer modeling, they are also focused on possible risks.